Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Garth Cosgrove

Neurological Surgery Boston, MA Medical Doctor

NPI 1649386988 CMS profile 523996

75 Francis Street, Brigham And Woman's Hospital-Neurosurgery, Boston, MA 02115

Open in the dashboard

General payments

$64,244

54 records reported · program years 2019–2025

Research payments

$2,700

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$378,459 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Garth Cosgrove of Boston, MA is reported in the CMS Open Payments database as having received $64,244 across 54 general payments and $2,700 in research payments paid to them. Separately, studies naming them as principal investigator received $378,459 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 88th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,350 9
2024 General $3,283 15
2024 Research $2,700 1
2023 General $2,843 4
2022 General $43,561 17
2021 General $9,647 7
2020 General $1,500 1
2019 General $61 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Garth Cosgrove
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Garth Cosgrove were reported at $3,350. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Garth Cosgrove Neurological Surgery median Middle half National median
2019 $61 $582 $138–$3,006 $163
2020 $1,500 $294 $76–$2,174 $114
2021 $9,647 $387 $105–$2,432 $132
2022 $43,561 $542 $139–$2,989 $149
2023 $2,843 $534 $145–$2,697 $160
2024 $3,283 $574 $155–$3,046 $164
2025 $3,350 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. InSightec,Inc $32,123 37 payments
  2. ClearPoint Neuro, Inc. $29,182 9 payments
  3. Boston Scientific Corporation $1,650 2 payments
  4. Merck Healthcare KGaA $800 1 payment
  5. Medtronic, Inc. $374 2 payments
  6. Medtronic USA, Inc. $61 1 payment
  7. Zimmer Biomet Holdings, Inc. $30 1 payment
  8. NeuroPace, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $54,862 16 payments
  2. Travel and Lodging $6,949 7 payments
  3. Food and Beverage $2,434 31 payments
Products named General payments · program years 2019–2025
  1. EXABLATE Neurology $30,834 25 payments
  2. CLEARPOINT $20,239 4 payments
  3. ClearPoint Neuro Workstation $7,443 4 payments
  4. Vercise $1,650 2 payments
  5. ClearPoint System $1,500 1 payment
  6. Exablate Neurology $1,289 12 payments
  7. ACTIVA $61 1 payment
  8. ROSA $30 1 payment
  9. MIDAS REX $30 1 payment
  10. RNS Neurostimulator Kit $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Novo Nordisk AS $2,700 1 payment

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$152,273

Medicare's payments for the services billed

Medicare patients

264

Average age 73

Services billed

486

113 women, 151 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 50%
Depression 36%
Ischemic heart disease 24%
Diabetes 20%
Chronic kidney disease 18%
Osteoporosis 18%
Cancer 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

55 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record